arrow
C

Carmela Pinnetti

National Institute for Infectious Diseases Lazzaro Spallanzani
H指数:27
被引数:2,494

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi

直接抗病毒药物在合并HCV感染的HIV相关非霍奇金淋巴瘤患者中的作用:意大利淋巴瘤基金会研究

2026-09-060
PRE
Late or missed HIV diagnosis during pregnancy is still occurring in a high-income country and represents a high risk of MTCT

妊娠期艾滋病病毒诊断延误或漏诊在高收入国家仍然存在,并构成母婴传播的高风险

2026-04-120
OAAI
Successful use of isavuconazole as secondary prophylaxis of cryptococcal meningitis in a person living with HIV and AIDS: a case report

伊曲康唑作为隐球菌脑膜炎的二级预防在一名HIV和艾滋病感染者中的成功应用:病例报告

2026-03-200
OA
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study)

从依非韦伦/恩曲他滨/替诺福韦二吡呋酯转换为比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺,用于病毒学抑制的HIV感染者:一项非随机临床试验(EBONY研究)的结果

2025-06-180
OAAI
Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognition
AIDS
IF3.1
2024-10-240
PRE
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study

根据先前的天花疫苗暴露和HIV感染,改良安卡拉痘苗暴露前疫苗的免疫原性和反应原性: 前瞻性队列研究

2024-02-018
OAAI
Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications
2024-02-0110
OAAI
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio

根据CD4计数和CD4/CD8比值SARS-CoV-2 HIV感染者的mRNA疫苗反应

2023-10-307
OAAI
Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes

在意大利参考医院因新型冠状病毒肺炎住院的患者中,在Delta和Omicron共循环期间关注的SARS-CoV-2变异的演变: 对临床结果的影响

2023-05-296
OAAI
Temporal intra-host variability of mpox virus genomes in multiple body tissues
2023-05-248
OAAI
What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis

post-COVID-19综合征对健康相关生活质量及相关因素的影响: 横断面分析

2023-03-2212
OAAI
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors
2022-10-1730
OAAI
Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals Living With HIV

近年来,人类免疫缺陷病毒 (HIV) 相关的神经认知障碍患病率下降,并在大量接受抗逆转录病毒治疗的HIV感染者中发现相关因素

2022-08-199
OAAI
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy
2022-04-202
OA
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
2022-04-02103
OAAI